home All News open_in_new Full Article

FDA upheaval pushes some biotech firms to plan early trials out of US

Some US biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs watchdog under the Trump administration may delay regulatory reviews, executives, investors, and consultants told Reuters. The US Food and Drug Administration is seen as the global gold standard […]


today 9 d. ago attach_file Politics

attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Sport
attach_file Politics
attach_file Politics
attach_file Sport
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Sport
attach_file Politics


ID: 2889349809
Add Watch Country

arrow_drop_down